Bacterial 30S ribosomal A-site (30S A-site)

The bacterial 30S ribosomal A-site is a critical functional region within the 16S ribosomal RNA of the small ribosomal subunit, serving as the decoding center during protein synthesis (Vicens & Westhof, 2001). Its primary biological role is to monitor the fidelity of codon-anticodon pairing between messenger RNA (mRNA) and aminoacyl-transfer RNA (tRNA). This site is the primary target for several classes of potent antibiotics, most notably aminoglycosides and tetracyclines, which are used to treat a wide range of bacterial infections (Brodersen et al., 2000). Aminoglycosides bind to the A-site and induce a conformational change that causes the ribosome to misread the genetic code, leading to the production of toxic, misfolded proteins (StatPearls, 2023). Tetracyclines function by sterically blocking the A-site, which prevents the entry of aminoacyl-tRNA and halts the elongation of the polypeptide chain. Because the bacterial A-site has distinct structural features compared to the human mitochondrial and cytoplasmic ribosomes, it allows for selective antimicrobial activity, although cross-reactivity can lead to side effects like ototoxicity. Resistance to drugs targeting this site often arises through enzymatic modification of the drugs or methylation of the 16S rRNA itself (PubMed, 2021).

Other names

16S rRNA A-siteDecoding centerAminoacyl-tRNA binding siteBacterial decoding siteRibosomal acceptor site

Antibiotics targeting the 30S A-site inhibit bacterial growth by either inducing mRNA misreading through conformational stabilization of the decoding center (aminoglycosides) or by sterically blocking the binding of aminoacyl-tRNA to the A-site, thereby preventing peptide chain elongation (tetracyclines).